AstraZeneca PLC

AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company known for its extensive research-driven approach to drug development. The company focuses on the discovery, development, and commercialization of prescription medicines, primarily in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca plays a crucial role in addressing critical healthcare needs and managing a diverse portfolio of medicines that serve millions of patients globally. Headquartered in Cambridge, United Kingdom, AstraZeneca holds a significant position in the pharmaceutical industry, continuously advancing human health through innovation in drug therapies and vaccines. The company is in strategic partnerships with various research institutions and universities to enhance its R&D capabilities. It utilizes state-of-the-art technology to accelerate drug discovery processes, which has made it a key player in tackling pressing health challenges, including its prominent role in vaccine development during the COVID-19 pandemic. With a commitment to improving patient outcomes and a robust pipeline of new medicines, AstraZeneca maintains its reputation as a leader in creating transformative treatments that address unmet medical needs.